Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Structure Therapeutics Inc. (GPCR) Balance Sheet

As of 2026-06-30 (10-Q), Structure Therapeutics Inc. (GPCR) reported total assets of $1.4B, total liabilities of $71.0M and shareholders' equity of $1.4B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $272.6M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

GPCRStructure Therapeutics Inc.Follow GPCR — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
1.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.130.170.800.27
Short-term investments0.340.710.651.07
Current assets0.470.891.571.37
Total assets0.480.901.581.43
Current liabilities0.020.040.060.07
Total liabilities0.030.040.070.07
Shareholders' equity0.450.861.521.35

USD billions · SEC XBRL

Structure Therapeutics Inc. — questions

How much cash does Structure Therapeutics Inc. have?
$272.6M in cash and cash equivalents as of 2026-06-30.
What are Structure Therapeutics Inc.'s total assets?
$1.4B as of 2026-06-30.
What is Structure Therapeutics Inc.'s shareholders' equity?
$1.4B as of 2026-06-30.

Every figure on this page comes from Structure Therapeutics Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.